GlassScriptPhysician profile
Bradley S King
NPI 1831165588
$2,795.44
in general payments reported to CMS, 2019-2025
42 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $665 · 2020: $53.32 · 2021: $171 · 2022: $503 · 2023: $419 · 2024: $637 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389 · Education: $14.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,389.11 |
| Education | $14.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $426.68 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $394.88 | 2019-2025 | Repatha, Otezla, Tepezza |
| Insulet Corporation | $193.61 | 2021-2024 | Omnipod |
| Lilly USA, LLC | $155.57 | 2019-2024 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.87 | 2019-2025 | Jardiance |
| Stryker Corporation | $134.24 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $104.93 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $99.70 | 2019 | |
| Medtronic, INC. | $83.86 | 2021-2025 | Minimed 780g |
| Abbvie INC. | $80.54 | 2021-2023 | |
| Abbott Laboratories | $78.01 | 2022 | |
| Corcept Therapeutics | $67.34 | 2025 | Korlym |
| Ascensia Diabetes Care US INC. | $61.54 | 2023-2024 | |
| Phathom Pharmaceuticals, INC. | $57.30 | 2024 | Voquezna |
| Pfizer INC. | $52.44 | 2019-2024 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.